Phase II Study of Proteasome Inhibitor PS-341 For Patients With Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy

This study has been terminated.

Study NCT00038571 Information provided by M.D. Anderson Cancer Center

First Received: May 31, 2002 Last Updated: August 11, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given